Clinical trial · Observational
Texture Features and PDL1 in CT-PET 18 FDG
Correlation Between Texture Features With CT-PET 18 FDG and Overexpression of PDL1 in Non-small-cell Lung Carcinomas During the Initial Staging.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Search correlation between texture features in CT-PET 18 FDG and overexpression of PDL1 in non-small cell lung carcinomas during the inital staging. The hypothesis is that overexpression of PDL1is correlated with at least one texture feature among those selected. 84 CT-PET 18 FDG at the initial staging of a non small cell lung carcinoma (adenocarcinoma or squamous cell carcinoma), whose the biopsed site was the primitive site or the drainage lymphadenopathy, without previous treatment, were recruited and analyzed by a software allowing to estimate texture features.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non Small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (2)
- label
- Overexpression of PDL1
- description
- Overexpression of PDL1
- label
- Absence of overexpression of PDL1
- description
- Absence of overexpression of PDL1
Primary outcomes (1)
- measure
- Correlation between at least one texture feature and overexpression of PDL1
- timeFrame
- 1 day
- description
- Correlation between at least one texture feature and overexpression of PDL1
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria: * adult patient ; * first CT-PET 18 FDG realized for the inital staging ; * absence of previous treatment for a thoracic neoplasm ; * biopsy realized on the primitive site or local drainage lymphadenopathy ; * primitive site viewable with morphological imagery ; * availability of evaluation of PDL1's overexpression ; Exclusion criteria \- Refusal to participate in this research
References
Publications (0)
Data not yet available